Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bikash R Meher

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tropical Doctor|February 11, 2020
Indication-specific pricing of drugs: a utopian idea, a pragmatic proposition or unrealistic in economically constrained settings?Bikash R Meher, Biswa M Padhy
Cureus|April 1, 2024
Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder: A New Biologic Agent Targeting the Interleukin-6 ReceptorBikash R Meher, Rashmi R Mohanty, Ashish Dash
Cureus|August 14, 2024
Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-AnalysisBikash R Meher, Archana Mishra, Biswanath Behera, et al.
Cureus|July 12, 2026
Phase III Trials in India: A Comprehensive Analysis of the Clinical Trials Registry-IndiaAjaya Sahoo, Bikash R Meher, Monalisa Jena, et al.
Journal of Pharmacy & Bioallied Sciences|March 26, 2019
Biosimilars in India; Current Status and Future PerspectivesBikash R Meher, Sakthi Balan, Rashmi R Mohanty, et al.
Cureus|April 10, 2023
Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority TrialAshish Dash, Bikash R Meher, Biswa M Padhy, et al.
Cureus|March 30, 2022
Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes MellitusBikash R Meher, Rashmi R Mohanty, Jyoti P Sahoo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tropical Doctor|February 11, 2020
Indication-specific pricing of drugs: a utopian idea, a pragmatic proposition or unrealistic in economically constrained settings?Bikash R Meher, Biswa M Padhy
Cureus|April 1, 2024
Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder: A New Biologic Agent Targeting the Interleukin-6 ReceptorBikash R Meher, Rashmi R Mohanty, Ashish Dash
Cureus|August 14, 2024
Efficacy and Safety of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Meta-AnalysisBikash R Meher, Archana Mishra, Biswanath Behera, et al.
Cureus|July 12, 2026
Phase III Trials in India: A Comprehensive Analysis of the Clinical Trials Registry-IndiaAjaya Sahoo, Bikash R Meher, Monalisa Jena, et al.
Journal of Pharmacy & Bioallied Sciences|March 26, 2019
Biosimilars in India; Current Status and Future PerspectivesBikash R Meher, Sakthi Balan, Rashmi R Mohanty, et al.
Cureus|April 10, 2023
Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority TrialAshish Dash, Bikash R Meher, Biswa M Padhy, et al.
Cureus|March 30, 2022
Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes MellitusBikash R Meher, Rashmi R Mohanty, Jyoti P Sahoo, et al.
Pageof 1